arrow up

Unless you somehow get incredibly lucky, buying and trading stocks won't get you rich overnight. However, putting your money into stocks with a high upside can help to offer you more financial freedom down the line. In order to offer you some guidance regarding potential stocks, we have consolidated information on some of the best growth stocks into one easy list! 

Growth Stock FAQ

FAQ

Photo credited by: chatbotslife.com

1. What Are Growth Stocks?

2. Where Can I Buy Growth Stocks?

3. Can I Lose Money Trading Stocks?

How We Reviewed

Reviewed

Photo credited by: industrios.com

The following stocks were reviewed based on their price, the market the company exists within, its current business model, and estimated price target.

Overall Price Range of Growth Stocks

graph

Photo credited by: fool.com

Growth stocks on this list range from costing around $ per share to $$$ per share. While a stock priced on the lower side may have more opportunity and room for growth, the more expensive stock options typically provide a bit more security in the sense that they have a proven track record of steady growth.

What We Reviewed

  • Etsy
  • Cloudera
  • Autodesk
  • Netflix
  • CBS Corp
  • Live Nation Entertainment
  • Abiomed
  • Neurocrine Biosciences
  • Helmerich & Payne
  • Sarepta Therapeutics

Etsy

Etsy logo

Photo credited by: en.wikipedia.org

Features

Having nearly doubled in value since the start of 2018, Etsy is quickly becoming a force in the market. An online e-commerce website, Etsy went public in 2015. After a slight dip following their IPO, Etsy steadily increased in value before exploding in 2018.

Pros

  • Consistent and steady growth is encouraging  
  • Price target of $51 means analysts still feel this stock has room to grow
  • One of the most cost effective growth stocks on this list

Cons

  • Some moves made recently seem to be more in favor of promoting collaboration with major manufacturers as opposed to the homemade boutique style that made Etsy what it is today 
  • Etsy is increasing fees across their platform and could potentially price out some of the unique sellers available on Etsy
  • Etsy has already experienced such growth that continued rapid expansion may not be sustainable

Price

At the time of this writing, this stock currently trades at around $$ per share.

Performance

One of the fastest growing stocks on this list, Etsy has outperformed just about all expectations so far in 2018. More than doubling in value at the time of this writing, Etsy is without a doubt one of the hottest growth stocks available.

Cloudera

Cloudera logo

Photo credited by: icc-usa.com

Features

Cloudera is a cloud-based software engineering company. Cloudera attempts to help businesses store and readily be able to filter and access any of the valuable market data that they may obtain. After a strong first month following their IPO in 2017, Cloudera stock has stumbled a few times and (at the time of this writing) currently sits as the lowest-priced of the growth stocks that made our list. However, a recent merger with Hortonworks has investors intrigued to see what is next for Cloudera.

Pros

  • Lowest priced stock on this list means you can buy more shares without having to reach deeper into your pockets
  • Merger with Hortonworks allows Cloudera to cut competition while helping to scale more quickly
  • Price target increased from nearly $13 pre-merger to roughly $23 post-merger
  • Cloud technology is a rapidly growing market sector

Cons

  • In a very saturated market with competitors such as Google, Amazon, and Microsoft
  • Still not a profitable company and may not be for a few more years
  • Sales projections are down year over year

Price

At the time of this writing, this stock currently trades at around $$ per share.

Performance

Although the Cloudera stock has stumbled on many occasions and sits priced below its 2017 IPO price, the Hortonworks merger offers an opportunity to scale in a much more efficient manner and potentially greatly increase the company's valuation. Cloudera is a textbook stock to be "cautiously optimistic" about.

Autodesk

Autodesk logo

Photo credited by: moddb.com

Features

Steadily gaining since its IPO back in 1985, Autodesk is one of the most time-tested growth stocks available on this list. Autodesk specializes in creating software to aid manufacturing, architecture, agriculture, and much more! Having nearly doubled in value over the past two years, Autodesk safely finds its way onto our list of the top growth stocks.

Pros

  • One of the oldest stocks on this list that has seen steady growth for the better part of 3 decades 
  • Price target of $165 means analysts feel the recent price surge will continue
  • Autodesk's move to a subscription-based model could yield higher earnings moving forward

Cons

  • Autodesk has not had a positive fiscal year since 2015
  • One of the more expensive stocks to trade on this list
  • Uncertainty regarding the switch to a subscription-based model and how the market will react

Price

At the time of this writing, this stock currently trades at around $$ per share.

Performance

With steady long-term gains in the market (except for the market crash in 2008-2009), Autodesk has seen uninterrupted growth. With a recent explosion in value over the past two years, many analysts are projecting the growth to continue as the general price target sits nearly $ above the current price of the stock.

Netflix

Netflix logo

Photo credited by: partner.netflix.com

Features

A staple of just about any millennial's daily life, Netflix continues to expand its reach into new and exciting endeavors. After moving from a DVD-based model to a streaming service, Netflix single-handedly changed the way millions of people consume media. Over the years, Netflix has expanded their arsenal from being simply a platform that hosts your favorite movies and shows, to one that actually produces and creates those shows in the first place!

Pros

  • Although the streaming space is about to get more crowded, Netflix has familiarity among users and some slick user experience compared to other platforms  
  • The move into content creation allows Netflix to create shows more suited to what its user base wants
  • Although rumors have been circling for years, Netflix remains a potential target on the radar of some massive technology corporations

Cons

  • The most expensive of any growth stock on this list
  • Due to the recent move towards content creation as opposed to simply a streaming platform, the value of Netflix will be much more tied to how the original content performs
  • Big players (i.e. Disney) are starting to make a move into the streaming world which could potentially siphon business away from Netflix

Price

At the time of this writing, this stock currently trades at around $$$ per share.

Performance

One of the strongest performing growth stocks on this list, Netflix has taken a massive leap since moving to a streaming service and continues to expand through its new content creation endeavors. With most price targets sitting around $$$, this expensive stock still likely has some room to grow!

CBS Corp

CBS Corp logo

Photo credited by: en.wikipedia.org

Features

CBS is one of the largest media players in the game and has fallen on some interesting times following the ousting of former CEO Les Moonves. Clocking in with the 5th highest overall revenue worldwide among major media corporations, CBS is one of the largest companies we will take a look at on our list of growth stocks.

Pros

  • Massive market cap tends to lead to more stability  
  • Price target of $64 means most analysts believe the stock will increase in value
  • Earnings projected to grow at a quicker rate than previous years

Cons

  • Lots of uncertainty regarding top level leadership of the company
  • No permanent CEO following the ousting of Les Moonves and the recent resignation of interim CEO Richard Parsons for health reasons
  • Although no longer the CEO, allegations regarding Les Moonves can potentially sour investors on the company

Price

At the time of this writing, this stock currently trades at around $ per share.

Performance

With the allegations surrounding former CEO Les Moonves, the CBS Corp stock has had a rocky few months. With a massive overhaul underway and a price target that sits above the current trading price, CBS Corp makes itself a prime candidate for a strong rebound.

Live Nation Entertainment

Live Nation Entertainment logo

Photo credited by: ravenpmg.com

Features

One of the pioneers of the entertainment world, Live Nation Entertainment is known for staying a step ahead of the competition. With their recent announcement to integrate blockchain technology into their widely used website Ticketmaster, Live Nation Entertainment shows us once again that they are willing to push limits to reach new markets.

Pros

  • New integration of blockchain technology into Ticketmaster is a unique step not seen by other companies on this list of growth stocks      
  • 2018 has been an extremely strong year, seeing Live Nation Entertainment shares raised nearly 23% in value
  • Stock has been steadily increasing since roughly 2010

Cons

  • FTC looking into online ticketing could mean potential setbacks for a major component of the business
  • Price target roughly even with where share prices sit meaning analysts do not foresee the price increasing
  • A New York Times article this year alleged that the justice department was looking into Live Nation's "behavior in the marketplace"

Price

At the time of this writing, this stock currently trades at around $ per share.

Performance

Although some government regulation concerns surround the future of Live Nation Entertainment, the stock has done nothing but continue to climb. Though most analysts do not see share prices rising much higher than where they currently sit, the integration of blockchain technology, if done successfully, could help to open new doors for Live Nation Entertainment.

Abiomed

Abiomed logo

Photo credited by: talkmarkets.com

Features

A medical implant device company, Abiomed has seen its price skyrocket since late 2017. A leader in the artificial heart market, Abiomed offers some unique appeal as many analysts feel there is considerable room to grow.

Pros

  • Price target set for nearly $100 above current share price, meaning analysts feel there is some serious room to grow 
  • Abiomed is known for being one of the most innovative companies, which is good for long-term prospects as well
  • One of the top performing stocks in the med tech space

Cons

  • One of the most expensive stocks on this list
  • Stock seems to hit some resistance around the $450 mark
  • While Abiomed has thrived, the medical device market has taken a small hit

Price

At the time of this writing, this stock currently trades at around $$$ per share.

Performance

Steadily gaining since its IPO in 1987, Abiomed has taken off since 2017 due to the approval and implementation of multiple new products. Though shares have hit some resistance around the $450 mark, many analysts feel the stock will eventually break through that ceiling.

Neurocrine Biosciences

Neurocrine Biosciences logo

Photo credited by: ticker.tv

Features

A biopharmaceutical company, Neurocrine Biosciences specializes in the treatment of Tardive Dyskinesia. Since 2010, the share prices have been on a steady rise topping out this year in the $$$ range.

Pros

  • Sales of a new drug have far exceeded expectations 
  • Stock has outperformed projections so far
  • Many other interesting drugs are in the works or pending approval

Cons

  • Drug just went to market in May
  • Limited market with a maximum of a few hundred thousand potential customers 
  • Price target not listed much higher than shares are currently priced

Price

At the time of this writing, this stock currently trades at around $$$ per share.

Performance

Steadily increasing in value since 2010, Neurocrine Biosciences has a strong track record coupled with an over-performing product. This confluence of events has led to record high share prices with an interesting potential for further growth.

Helmerich & Payne

Helmerich & Payne logo

Photo credited by: resources.techcommunity.microsoft.com

Features

An oil drilling company that has been publicly traded since 1981, Helmerich & Payne is the oldest publicly traded company to find itself on our list of the best growth stocks. A leader in efficient drilling and environmentally friendly drilling technology, Helmerich & Payne is set up at an interesting crossroads given the world's current view on petroleum.

Pros

  • Specializes in efficient oil drilling methods 
  • Stock has some momentum and may be worth buying and selling shortly after
  • Some major firms still have Helmerich and Payne listed as a strong buy

Cons

  • Price target listed only slightly above where shares currently trade
  • Changing world climate is moving away from petroleum in general
  • Volatile share prices since 2014

Price

At the time of this writing, this stock currently trades at around $$ per share.

Performance

After peaking in 2014, it has been a rocky few years for Helmerich & Payne. The stock has been fairly volatile trending between around $ and $$.

Sarepta Therapeutics

Sarepta Therapeutics logo

Photo credited by: owler.com

Features

A medical research and drug development company, Sarepta Therapeutics is specifically a leader in the field of Ebola research and prevention. That said, there are a wide range of diseases that Sarepta focuses its energy towards in both research and drug development.

Pros

  • With a price target of $170, most analysts believe that this stock has some room to grow  
  • Research work is done on a wide range of diseases so a breakthrough could lead to massive shareholder profits
  • Pioneers in the new field of gene therapy which could lead to shareholder profits

Cons

  • Volatile price history leads to some uncertainty
  • Price increase heavily dependent on approval for new drugs that are still being worked on
  • If drugs fall short and do not get approved, investors could be left hurting

Price

At the time of this writing, this stock currently trades at around $$$ per share.

Performance

Peaking in value in both 2000 as well as in 2018 at around $$ per share, Sarepta Therapeutics has been much more consistent regarding growth this time around. Compared to the 2000 flash-in-a-pan price increase and subsequent decrease, 2018's rise has been slowly built up over years of strong decisions.

The Verdict

All in all, Abiomed seems to offer the biggest room for growth among these stocks while offering minimal risk, compared to some other options on our list. Although it certainly clocks in at a higher price compared to some other options on this list, the optimism for its outlook is unmatched by other growth stocks on our list.

(Visited 14 times, 1 visits today)

Pin It on Pinterest